• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Medulloblastoma, Childhood

Medulloblastoma, Childhood - 13 Studies Found

Completed : Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Suprate
    : 2006-06-08
    :
    • Drug: etoposide Given IV

Completed : Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor
:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Suprate
    : 2000-11-06
    :
    • Drug: cisplatin Given IV

Active, not recruiting : Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
:
  • Recurrent Childhood Medulloblastoma
  • Recurrent Childhood Pineobl
    : 2010-10-07
    :
    • Biological: Bevacizumab Given

Active, not recruiting : Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Pineobl
    : 2009-03-20
    :
    • Radiation: 3-Dimensional Conformal Radiation Therapy

Recruiting : Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Pineobl
    : 2006-10-25
    :
    • Radiation: Radiation Therapy U

Suspended : Gallium Ga 68-Edotreotide PET/CT Compared With Indium In 111 Pentetreotide Plus Contrast-Enhanced CT (or MRI) in Diagnosing Patients With Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
:
  • Adult Medulloblastoma
  • Childhood Medulloblastoma
  • : 2013-05-31
    :
    • Radiation: gallium Ga 68-edotreotide

Recruiting : WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
:
  • Childhood Central Nervous System Neoplasm
  • Recurrent Childhood Medullob
    : 2014-03-13
    :
    • Drug: Irinotecan Hydrochloride

Recruiting : Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
: Brain and Central Nervous System Tumors
: 2006-01-12
:
  • Drug: cisplatin
  • Drug: lomustine

Completed : Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
:
  • Brain Tumors
  • Central Nervous System Tumors

: 1999-11-01
:
  • Biological: filgrastim Other N

Completed : Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
:
  • Brain Tumors
  • Central Nervous System Tumors

: 1999-11-01
:
  • Biological: filgrastim Other N

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.